China Health Valuation
| CHHE Stock | USD 0.28 0.04 12.50% |
China Health seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of China Health Industries from analyzing the firm fundamentals such as Current Valuation of (25.17 M), shares owned by insiders of 31.29 %, and Return On Equity of -0.0186 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that China Health's price fluctuation is out of control at this time. Calculation of the real value of China Health Industries is based on 3 months time horizon. Increasing China Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the China pink sheet is determined by what a typical buyer is willing to pay for full or partial control of China Health Industries. Since China Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of China Pink Sheet. However, China Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.28 | Real 0.25 | Hype 0.28 | Naive 0.33 |
The real value of China Pink Sheet, also known as its intrinsic value, is the underlying worth of China Health Industries Company, which is reflected in its stock price. It is based on China Health's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of China Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of China Health Industries helps investors to forecast how China pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of China Health more accurately as focusing exclusively on China Health's fundamentals will not take into account other important factors: China Health Total Value Analysis
China Health Industries is currently forecasted to have valuation of (25.17 M) with market capitalization of 10.5 M, debt of 6.76 M, and cash on hands of 44.79 M. The negative valuation of China Health may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the China Health fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(25.17 M) | 10.5 M | 6.76 M | 44.79 M |
China Health Investor Information
About 31.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.28. Some equities with similar Price to Book (P/B) outperform the market in the long run. China Health Industries recorded a loss per share of 0.02. The entity had not issued any dividends in recent years. The firm had 1:20 split on the 13th of November 2008. China Health Industries is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.China Health Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. China Health has an asset utilization ratio of 5.26E-4 percent. This indicates that the Company is making $5.0E-6 for each dollar of assets. An increasing asset utilization means that China Health Industries is more efficient with each dollar of assets it utilizes for everyday operations.China Health Ownership Allocation
China Health holds a total of 65.54 Million outstanding shares. China Health Industries retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.China Health Profitability Analysis
The company reported the previous year's revenue of 267. Net Loss for the year was (353.95 K) with loss before overhead, payroll, taxes, and interest of (1.48 K).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates China Health's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in China Health and how it compares across the competition.
About China Health Valuation
The pink sheet valuation mechanism determines China Health's current worth on a weekly basis. Our valuation model uses a comparative analysis of China Health. We calculate exposure to China Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of China Health's related companies.China Health Industries Holdings, Inc., through its subsidiaries, manufactures and sells health products. The company is based in Harbin City, the Peoples Republic of China. China Health operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 45 people.
8 Steps to conduct China Health's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates China Health's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct China Health's valuation analysis, follow these 8 steps:- Gather financial information: Obtain China Health's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine China Health's revenue streams: Identify China Health's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research China Health's industry and market trends, including the size of the market, growth rate, and competition.
- Establish China Health's growth potential: Evaluate China Health's management, business model, and growth potential.
- Determine China Health's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate China Health's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
China Health Growth Indicators
Investing in growth stocks can be very risky. If the company such as China Health does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 65.5 M | |
| Quarterly Earnings Growth Y O Y | -0.897 | |
| Retained Earnings | 41.7 M |
Complementary Tools for China Pink Sheet analysis
When running China Health's price analysis, check to measure China Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy China Health is operating at the current time. Most of China Health's value examination focuses on studying past and present price action to predict the probability of China Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move China Health's price. Additionally, you may evaluate how the addition of China Health to your portfolios can decrease your overall portfolio volatility.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |